APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Pen

Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.

Insulin pen prevents the patient from the cumbersome procedure of extraction with a syringe from the insulin bottle; reduce embarrassment in public; supply convenience for poor vision and even blindness sufferers.

Selected research

Market Outlook & Growth Opportunities

Global Insulin Pen Market Outlook and Growth Opportunities 2026

26 December 2025193 pages

Choose your research edition.

Industry ResearchInsulin Pen Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Pen Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Insulin Pen Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Pen Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Pen Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Insulin Pen is a kind of insulin injection device, slightly larger in size than the pen, insulin refill in the pen. It’s easy to carry at users’ ease. The way to function is to fit with specific refill filled with insulin, fix the needle and pull off the needle cover. The operation is very convenient.

Insulin pen prevents the patient from the cumbersome procedure of extraction with a syringe from the insulin bottle; reduce embarrassment in public; supply convenience for poor vision and even blindness sufferers.

EU is the largest Insulin Pen market with about 48% market share. Asia is follower, accounting for about 27% market share.

Read the full market overview

The key players are Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee etc. Top 3 companies occupied about 69% market share.

This report provides an overview of the global Insulin Pen market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Insulin Pen and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Insulin Pen sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Insulin Pen market size, projected growth trends, production technologies, key applications, and end-use industries.

Insulin Pen Segment by Company

Novo Nordisk

Eli Lilly

Sanofi

BD

Ypsomed Holding

Dongbao

Owen Mumford

Ganlee

Insulin Pen Segment by Type

Reusable Insulin Pen

Disposable Insulin Pen

Insulin Pen Segment by Application

Hospitals

Clinics

The Chemist's Shops

Insulin Pen Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Insulin Pen status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Insulin Pen market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Insulin Pen significant trends, drivers, influence factors in global and regions.

6. To analyze Insulin Pen competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Pen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Pen and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Pen.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insulin Pen market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Insulin Pen industry.

Chapter 3: Detailed analysis of Insulin Pen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Insulin Pen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Insulin Pen in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Insulin Pen Industry Trends Table 2. Insulin Pen Industry Drivers Table 3. Insulin Pen Industry Opportunities and Challenges Table 4. Insulin Pen Industry Restraints Table 5. Global Insulin Pen Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Insulin Pen Revenue Share by Company (2021-2026) Table 7. Global Insulin Pen Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Insulin Pen Sales Volume Share by Company (2021-2026) Table 9. Global Insulin Pen Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Insulin Pen Company Ranking, (2024-2026) & (USD Million) Table 11. Global Insulin Pen Key Company Manufacturing Base & Headquarters Table 12. Global Insulin Pen Company, Product Type & Application Table 13. Global Insulin Pen Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Insulin Pen by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Reusable Insulin Pen Table 18. Significant Companies of Disposable Insulin Pen Table 19. Global Insulin Pen Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Insulin Pen Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Insulin Pen Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Insulin Pen Sales Volume Share by Type (2021-2026) Table 23. Global Insulin Pen Sales Volume Share by Type (2027-2032) Table 24. Global Insulin Pen Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Insulin Pen Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Insulin Pen Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Insulin Pen Sales Value Share by Type (2021-2026) Table 28. Global Insulin Pen Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Clinics Table 31. Significant Companies of The Chemist's Shops Table 32. Global Insulin Pen Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Insulin Pen Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Insulin Pen Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Insulin Pen Sales Volume Share by Application (2021-2026) Table 36. Global Insulin Pen Sales Volume Share by Application (2027-2032) Table 37. Global Insulin Pen Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Insulin Pen Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Insulin Pen Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Insulin Pen Sales Value Share by Application (2021-2026) Table 41. Global Insulin Pen Sales Value Share by Application (2027-2032) Table 42. Global Insulin Pen Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Insulin Pen Sales by Region (2021-2026) & (K Units) Table 44. Global Insulin Pen Sales Market Share by Region (2021-2026) Table 45. Global Insulin Pen Sales by Region (2027-2032) & (K Units) Table 46. Global Insulin Pen Sales Market Share by Region (2027-2032) Table 47. Global Insulin Pen Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Insulin Pen Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Insulin Pen Sales Value Share by Region (2021-2026) Table 50. Global Insulin Pen Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Insulin Pen Sales Value Share by Region (2027-2032) Table 52. Global Insulin Pen Market Average Price (USD/Unit) by Region (2021-2026) Table 53. Global Insulin Pen Market Average Price (USD/Unit) by Region (2027-2032) Table 54. Global Insulin Pen Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Insulin Pen Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Insulin Pen Sales by Country (2021-2026) & (K Units) Table 57. Global Insulin Pen Sales Market Share by Country (2021-2026) Table 58. Global Insulin Pen Sales by Country (2027-2032) & (K Units) Table 59. Global Insulin Pen Sales Market Share by Country (2027-2032) Table 60. Global Insulin Pen Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Insulin Pen Sales Value Market Share by Country (2021-2026) Table 62. Global Insulin Pen Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Insulin Pen Sales Value Market Share by Country (2027-2032) Table 64. Novo Nordisk Company Information Table 65. Novo Nordisk Business Overview Table 66. Novo Nordisk Insulin Pen Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 67. Novo Nordisk Insulin Pen Product Portfolio Table 68. Novo Nordisk Recent Development Table 69. Eli Lilly Company Information Table 70. Eli Lilly Business Overview Table 71. Eli Lilly Insulin Pen Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 72. Eli Lilly Insulin Pen Product Portfolio Table 73. Eli Lilly Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Insulin Pen Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 77. Sanofi Insulin Pen Product Portfolio Table 78. Sanofi Recent Development Table 79. BD Company Information Table 80. BD Business Overview Table 81. BD Insulin Pen Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 82. BD Insulin Pen Product Portfolio Table 83. BD Recent Development Table 84. Ypsomed Holding Company Information Table 85. Ypsomed Holding Business Overview Table 86. Ypsomed Holding Insulin Pen Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 87. Ypsomed Holding Insulin Pen Product Portfolio Table 88. Ypsomed Holding Recent Development Table 89. Dongbao Company Information Table 90. Dongbao Business Overview Table 91. Dongbao Insulin Pen Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Dongbao Insulin Pen Product Portfolio Table 93. Dongbao Recent Development Table 94. Owen Mumford Company Information Table 95. Owen Mumford Business Overview Table 96. Owen Mumford Insulin Pen Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Owen Mumford Insulin Pen Product Portfolio Table 98. Owen Mumford Recent Development Table 99. Ganlee Company Information Table 100. Ganlee Business Overview Table 101. Ganlee Insulin Pen Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Ganlee Insulin Pen Product Portfolio Table 103. Ganlee Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Insulin Pen Distributors List Table 107. Insulin Pen Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Insulin Pen Product Image Figure 2. Global Insulin Pen Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Pen Sales Value (2021-2032) & (US$ Million) Figure 4. Global Insulin Pen Sales (2021-2032) & (K Units) Figure 5. Global Insulin Pen Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Insulin Pen Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Reusable Insulin Pen Image Figure 10. Disposable Insulin Pen Image Figure 11. Global Insulin Pen Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Insulin Pen Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Insulin Pen Sales Volume Share by Type (2021-2032) Figure 14. Global Insulin Pen Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Insulin Pen Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Insulin Pen Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Clinics Image Figure 19. The Chemist's Shops Image Figure 20. Global Insulin Pen Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Insulin Pen Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Insulin Pen Sales Volume Share by Application (2021-2032) Figure 23. Global Insulin Pen Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Insulin Pen Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Insulin Pen Sales Value Share by Application (2021-2032) Figure 26. Global Insulin Pen Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Insulin Pen Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Insulin Pen Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Insulin Pen Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Insulin Pen Sales Value (2021-2032) & (US$ Million) Figure 31. North America Insulin Pen Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Insulin Pen Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Insulin Pen Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Insulin Pen Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Insulin Pen Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Insulin Pen Sales Value (2021-2032) & (US$ Million) Figure 37. South America Insulin Pen Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Insulin Pen Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Insulin Pen Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Insulin Pen Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Insulin Pen Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Insulin Pen Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Insulin Pen Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Insulin Pen Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Reusable Insulin Pen
  • Disposable Insulin Pen
Applications
  • Hospitals
  • Clinics
  • The Chemist's Shops
Companies covered
  • Novo Nordisk
  • Eli Lilly
  • Sanofi
  • BD
  • Ypsomed Holding
  • Dongbao
  • Owen Mumford
  • Ganlee

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Insulin Pen Sales Value (2021-2032)
  4. 1.2.2 Global Insulin Pen Sales Volume (2021-2032)
  5. 1.2.3 Global Insulin Pen Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Insulin Pen Market Dynamics
  1. 2.1 Insulin Pen Industry Trends
  2. 2.2 Insulin Pen Industry Drivers
  3. 2.3 Insulin Pen Industry Opportunities and Challenges
  4. 2.4 Insulin Pen Industry Restraints
3 Insulin Pen Market by Company
  1. 3.1 Global Insulin Pen Company Revenue Ranking in 2025
  2. 3.2 Global Insulin Pen Revenue by Company (2021-2026)
  3. 3.3 Global Insulin Pen Sales Volume by Company (2021-2026)
  4. 3.4 Global Insulin Pen Average Price by Company (2021-2026)
  5. 3.5 Global Insulin Pen Company Ranking (2024-2026)
  6. 3.6 Global Insulin Pen Company Manufacturing Base and Headquarters
  7. 3.7 Global Insulin Pen Company Product Type and Application
  8. 3.8 Global Insulin Pen Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Insulin Pen Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Insulin Pen Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Insulin Pen Market by Type
  1. 4.1 Insulin Pen Type Introduction
  2. 4.1.1 Reusable Insulin Pen
  3. 4.1.2 Disposable Insulin Pen
  4. 4.2 Global Insulin Pen Sales Volume by Type
  5. 4.2.1 Global Insulin Pen Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Insulin Pen Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Insulin Pen Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Insulin Pen Sales Value by Type
  9. 4.3.1 Global Insulin Pen Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Insulin Pen Sales Value by Type (2021-2032)
  11. 4.3.3 Global Insulin Pen Sales Value Share by Type (2021-2032)
5 Insulin Pen Market by Application
  1. 5.1 Insulin Pen Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 The Chemist's Shops
  5. 5.2 Global Insulin Pen Sales Volume by Application
  6. 5.2.1 Global Insulin Pen Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Insulin Pen Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Insulin Pen Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Insulin Pen Sales Value by Application
  10. 5.3.1 Global Insulin Pen Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Insulin Pen Sales Value by Application (2021-2032)
  12. 5.3.3 Global Insulin Pen Sales Value Share by Application (2021-2032)
6 Insulin Pen Regional Sales and Value Analysis
  1. 6.1 Global Insulin Pen Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Insulin Pen Sales by Region (2021-2032)
  3. 6.2.1 Global Insulin Pen Sales by Region: 2021-2026
  4. 6.2.2 Global Insulin Pen Sales by Region (2027-2032)
  5. 6.3 Global Insulin Pen Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Insulin Pen Sales Value by Region (2021-2032)
  7. 6.4.1 Global Insulin Pen Sales Value by Region: 2021-2026
  8. 6.4.2 Global Insulin Pen Sales Value by Region (2027-2032)
  9. 6.5 Global Insulin Pen Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Insulin Pen Sales Value (2021-2032)
  12. 6.6.2 North America Insulin Pen Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Insulin Pen Sales Value (2021-2032)
  15. 6.7.2 Europe Insulin Pen Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Insulin Pen Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Insulin Pen Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Insulin Pen Sales Value (2021-2032)
  21. 6.9.2 South America Insulin Pen Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Insulin Pen Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Insulin Pen Sales Value Share by Country, 2025 VS 2032
7 Insulin Pen Country-level Sales and Value Analysis
  1. 7.1 Global Insulin Pen Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Insulin Pen Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Insulin Pen Sales by Country (2021-2032)
  4. 7.3.1 Global Insulin Pen Sales by Country (2021-2026)
  5. 7.3.2 Global Insulin Pen Sales by Country (2027-2032)
  6. 7.4 Global Insulin Pen Sales Value by Country (2021-2032)
  7. 7.4.1 Global Insulin Pen Sales Value by Country (2021-2026)
  8. 7.4.2 Global Insulin Pen Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Insulin Pen Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Insulin Pen Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Insulin Pen Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Insulin Pen Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Insulin Pen Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Insulin Pen Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Insulin Pen Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Insulin Pen Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Insulin Pen Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Insulin Pen Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Insulin Pen Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Insulin Pen Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Insulin Pen Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Insulin Pen Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Insulin Pen Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Insulin Pen Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Insulin Pen Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Insulin Pen Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Insulin Pen Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Insulin Pen Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Insulin Pen Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Insulin Pen Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Insulin Pen Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Insulin Pen Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Insulin Pen Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Insulin Pen Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Insulin Pen Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Insulin Pen Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Insulin Pen Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Insulin Pen Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Insulin Pen Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Insulin Pen Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Insulin Pen Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Insulin Pen Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Insulin Pen Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Insulin Pen Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Insulin Pen Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Insulin Pen Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Insulin Pen Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Insulin Pen Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Insulin Pen Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Insulin Pen Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Insulin Pen Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Insulin Pen Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Insulin Pen Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Insulin Pen Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Insulin Pen Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Insulin Pen Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Insulin Pen Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Insulin Pen Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Insulin Pen Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Insulin Pen Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Insulin Pen Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Insulin Pen Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Insulin Pen Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Insulin Pen Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Insulin Pen Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Insulin Pen Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Insulin Pen Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Insulin Pen Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Insulin Pen Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Insulin Pen Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Insulin Pen Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Insulin Pen Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Insulin Pen Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Insulin Pen Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Insulin Pen Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Insulin Pen Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Insulin Pen Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Insulin Pen Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Insulin Pen Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Insulin Pen Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Insulin Pen Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Insulin Pen Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Insulin Pen Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Insulin Pen Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Insulin Pen Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Insulin Pen Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Insulin Pen Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Insulin Pen Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Insulin Pen Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Insulin Pen Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Insulin Pen Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Insulin Pen Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novo Nordisk
  2. 8.1.1 Novo Nordisk Company Information
  3. 8.1.2 Novo Nordisk Business Overview
  4. 8.1.3 Novo Nordisk Insulin Pen Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novo Nordisk Insulin Pen Product Portfolio
  6. 8.1.5 Novo Nordisk Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Insulin Pen Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Insulin Pen Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Insulin Pen Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Insulin Pen Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 BD
  20. 8.4.1 BD Company Information
  21. 8.4.2 BD Business Overview
  22. 8.4.3 BD Insulin Pen Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BD Insulin Pen Product Portfolio
  24. 8.4.5 BD Recent Developments
  25. 8.5 Ypsomed Holding
  26. 8.5.1 Ypsomed Holding Company Information
  27. 8.5.2 Ypsomed Holding Business Overview
  28. 8.5.3 Ypsomed Holding Insulin Pen Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ypsomed Holding Insulin Pen Product Portfolio
  30. 8.5.5 Ypsomed Holding Recent Developments
  31. 8.6 Dongbao
  32. 8.6.1 Dongbao Company Information
  33. 8.6.2 Dongbao Business Overview
  34. 8.6.3 Dongbao Insulin Pen Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Dongbao Insulin Pen Product Portfolio
  36. 8.6.5 Dongbao Recent Developments
  37. 8.7 Owen Mumford
  38. 8.7.1 Owen Mumford Company Information
  39. 8.7.2 Owen Mumford Business Overview
  40. 8.7.3 Owen Mumford Insulin Pen Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Owen Mumford Insulin Pen Product Portfolio
  42. 8.7.5 Owen Mumford Recent Developments
  43. 8.8 Ganlee
  44. 8.8.1 Ganlee Company Information
  45. 8.8.2 Ganlee Business Overview
  46. 8.8.3 Ganlee Insulin Pen Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Ganlee Insulin Pen Product Portfolio
  48. 8.8.5 Ganlee Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Insulin Pen Value Chain Analysis
  2. 9.1.1 Insulin Pen Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Insulin Pen Sales Mode & Process
  6. 9.2 Insulin Pen Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Insulin Pen Distributors
  9. 9.2.3 Insulin Pen Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst